In situ hybridization - invicro
Ended Purchase Order Awarded Last action
- Contract number
- 75N95020P00762
- Awardee
-
Invicro LLC UEI NCNZRA2WSKC5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $25,025
Award facts
- Opportunity
-
- NIHNINDSCSS20008744 Solicitation number
- Contract value 100% obligated
- $25,024.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02210, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,002 | |
| Supplemental Agreement for work within scope | $7,002 | |
| Original award | $25,025 |
About this award
The National Institute on Drug Abuse awarded a purchase order to Invicro LLC for in situ hybridization services, with a ceiling value of $25,024.80 and an award date of September 28, 2020. Work is performed in Boston, Massachusetts, with an ultimate completion date of September 29, 2021. The purchase order is firm fixed price.
Quick answers
Who was awarded contract 75N95020P00762?
75N95020P00762 was awarded to Invicro LLC by National Institute on Drug Abuse (National Institutes of Health) on September 28, 2020.
How much is contract 75N95020P00762 worth?
The government has obligated $25,025 on 75N95020P00762.
Was contract 75N95020P00762 competed?
The extent of competition for 75N95020P00762 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award